Annual Statements Open main menu

RELIV INTERNATIONAL INC - Quarter Report: 2005 June (Form 10-Q)



FORM 10-Q

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2005

Commission File No. 1-11768

RELIV’ INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

37-1172197

(State or other jurisdiction of

 

(I.R.S. Employer Identification Number)

incorporation or organization)

 

 

136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005
(Address of principal executive offices) (Zip Code)

(636) 537-9715
(Registrant’s telephone number, including area code)

          Registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and has been subject to such filing requirements for the past 90 days.

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes x   No o

          As of June 30, 2005, 15,521,581 shares of the Registrant’s common stock were outstanding.



 

 

Part I.

FINANCIAL INFORMATION

 

 

Item 1.

Financial Statements

          The following consolidated financial statements of the Registrant are attached to this Form 10-Q:

 

 

 

 

1.

Interim Balance Sheet as of June 30, 2005 and Balance Sheet as of December 31, 2004.

 

 

 

 

2.

Interim Statements of Income for the three- and six-month periods ended June 30, 2005 and June 30, 2004.

 

 

 

 

3.

Interim Statements of Cash Flows for the six-month periods ended June 30, 2005 and June 30, 2004.

The Financial Statements reflect all adjustments which are, in the opinion of management, necessary for a fair statement of results for the periods presented.

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

          Overview

          The Company produces a line of food products including nutritional supplements, diet management products and sports drink mixes.  The Company also sells a line of skin care products.  These products are sold by subsidiaries of the Company to a sales force of independent distributors of the Company that sell products directly to consumers. The Company and its subsidiaries sell products to distributors throughout the United States and in Australia/New Zealand, Canada, Mexico, the United Kingdom/Ireland, the Philippines, Malaysia, and Singapore.  As of June 30, 2005, the Company had approximately 70,230 distributors worldwide.

          The Company receives payment by credit card, personal check or guaranteed funds for orders from independent distributors and makes related commission payments in the following month. The net sales price is the suggested retail price less the distributor discount of 20% to 40% of such suggested retail price. Sales revenue and commission expenses are recorded when the merchandise is shipped.  In the six months ended June 30, 2005, sales in the United States made up approximately 90% of worldwide net sales, with the remainder from our international operations.  This compares to 86% for all of 2004.  The sales breakdown by country is given in greater detail in the “Net Sales by Region” table below.

          Cost of products sold primarily consists of expenses related to raw materials, labor, quality control and overhead directly associated with the production and

2


distribution of products and sales materials, as well as shipping costs, duties and taxes associated with product exports.

          Distributor royalties and commissions are paid to Master Affiliates monthly, based on the sales of their distributor organization in the prior month.  These expenses are governed by the distributor agreements.  Also, included in this payment are other sales leadership bonuses that are directly related to the level of sales.

          Selling, general and administrative expenses include compensation and benefits, all other selling expenses, marketing, promotional expenses, travel and other corporate administrative expenses.

          Results of Operations

          The Company had net income available to common shareholders of $1,979,000 ($0.12 per share basic and $0.12 per share diluted) for the quarter ended June 30, 2005, compared to net income available to common shareholders of $1,201,000 ($0.08 per share basic and $0.07 per share diluted) for the same period in 2004. Profitability continued to improve as net sales improved worldwide by 19%, led by a 28% increase in net sales in the United States, the Company’s primary market.  

          For the six months ended June 30, 2005, net income available to common shareholders was $4,042,000 ($0.25 per share basic and $0.24 per share diluted) compared to $2,830,000 ($0.19 per share basic and $0.17 per share diluted) for the six months ended June 30, 2004.

          The following table summarizes the net sales by geographic region for the three-month periods ended June 30, 2005 and 2004. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales by Region

 

Three months ended June 30

 

 

 

 

 

 

 

(in thousands)

 

2005

 

2004

 

Change from

 

 

 

 

 

 

 

$

 

 

% of sales

 

 

$

 

 

% of sales

 

prior year

 

Change in %

 

 

 


 


 

United States

 

$

26,088

 

 

91.4

%

$

20,446

 

 

85.6

%

$

5,642

 

 

27.6

%

Australia/New Zealand

 

 

505

 

 

1.8

%

 

565

 

 

2.4

%

 

(60

)

 

-10.6

%

Canada

 

 

456

 

 

1.6

%

 

378

 

 

1.6

%

 

78

 

 

20.6

%

Mexico

 

 

293

 

 

1.0

%

 

664

 

 

2.8

%

 

(371

)

 

-55.9

%

United Kingdom/Ireland

 

 

235

 

 

0.8

%

 

145

 

 

0.6

%

 

90

 

 

62.1

%

Philippines

 

 

479

 

 

1.7

%

 

674

 

 

2.8

%

 

(195

)

 

-28.9

%

Malaysia/Singapore

 

 

490

 

 

1.7

%

 

1,019

 

 

4.3

%

 

(529

)

 

-51.9

%

 

 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated total

 

$

28,546

 

 

100.0

%

$

23,891

 

 

100.0

%

$

4,655

 

 

19.5

%

 

 


 


 

          The following table summarizes the net sales by geographic region for the six-month periods ended June 30, 2005 and 2004. 

3


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales by Region

 

Six months ended June 30

 

 

 

 

 

 

(in thousands)

 

2005

 

 

2004

 

Change from

 

 

 

 

 

 

$

 

 

% of sales

 

$

 

 

% of sales

 

prior year

 

Change in %

 

 

 


 

 


 

United States

 

$

52,057

 

 

90.5

%

$

41,017

 

 

86.6

%

$

11,040

 

 

26.9

%

Australia/New Zealand

 

 

1,081

 

 

1.9

%

 

1,158

 

 

2.4

%

 

(77

)

 

-6.6

%

Canada

 

 

907

 

 

1.6

%

 

776

 

 

1.6

%

 

131

 

 

16.9

%

Mexico

 

 

835

 

 

1.5

%

 

1,335

 

 

2.8

%

 

(500

)

 

-37.5

%

United Kingdom/Ireland

 

 

402

 

 

0.7

%

 

289

 

 

0.6

%

 

113

 

 

39.1

%

Philippines

 

 

1,280

 

 

2.2

%

 

1,370

 

 

2.9

%

 

(90

)

 

-6.6

%

Malaysia/Singapore

 

 

963

 

 

1.7

%

 

1,424

 

 

3.0

%

 

(461

)

 

-32.4

%

 

 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated total

 

$

57,525

 

 

100.0

%

$

47,369

 

 

100.0

%

$

10,156

 

 

21.4

%

 

 


 


 

          The following table illustrates the Company’s active distributors and Master Affiliates as of June 30, 2005 and 2004.  The total amount of distributors also includes the Master Affiliates.  The Company defines an active distributor as one that enrolls as a distributor or renews their distributorship during the prior twelve months.  Growth in the number of active distributors and Master Affiliates is a key factor in continuing the growth of the business.

Active Distributors and Master Affiliates by Region

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

as of 6/30/2005

 

as of 6/30/2004

 

Change in %

 

 

 

 

 

 

 

Master

 

 

 

 

Master

 

 

 

 

Master

 

 

 

Distributors

 

Affiliates

 

Distributors

 

Affiliates

 

Distributors

 

Affiliates

 

 

 


 


United States

 

 

50,240

 

 

13,090

 

 

45,040

 

 

9,870

 

 

11.5

%

 

32.6

%

Australia/New Zealand

 

 

2,790

 

 

240

 

 

2,770

 

 

230

 

 

0.7

%

 

4.3

%

Canada

 

 

1,370

 

 

190

 

 

1,350

 

 

160

 

 

1.5

%

 

18.8

%

Mexico

 

 

5,880

 

 

420

 

 

7,740

 

 

760

 

 

-24.0

%

 

-44.7

%

United Kingdom/Ireland

 

 

530

 

 

60

 

 

410

 

 

50

 

 

29.3

%

 

20.0

%

Philippines

 

 

5,640

 

 

500

 

 

6,510

 

 

580

 

 

-13.4

%

 

-13.8

%

Malaysia/Singapore

 

 

3,780

 

 

680

 

 

4,080

 

 

520

 

 

-7.4

%

 

30.8

%

 

 

 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated total

 

 

70,230

 

 

15,180

 

 

67,900

 

 

12,170

 

 

3.4

%

 

24.7

%

 

 

 


 


          In the United States, new distributor enrollments, strong retention and strong growth in the number of Master Affiliates continue to be factors in the increased sales in this market. In the first six months of 2005, over 12,700 new distributors were enrolled, as compared to approximately 12,200 in the same period of 2004.  Distributor retention was approximately 62%, compared to a rate of 58% for all of 2004.  The number of distributors reaching Master Affiliate, the highest level of discount a distributor can attain, has also continued to improve in the United States.  In the first six months of 2005, over 4,400 distributors achieved Master Affiliate status, as compared to approximately 3,600 in the same period of 2004.  The Company attributes the increase in sales and other sales statistics in part to the momentum created by the consistency and reinforcement of its training programs and business opportunity presentations, in the form of regional distributor conferences and other corporate-sponsored meetings.  This has resulted in

4


more distributors reaching the Master Affiliate level, who are more experienced and productive distributors.

          Also contributing to the sales increase in the second quarter of 2005 are sales from the introduction of the Company’s newest product, CardioSentials®.  Introduced in February 2005, net sales of this product were $1,102,000 in the second quarter of 2005.

           During the second quarter of 2005, sales in the Company’s international subsidiaries declined overall.  In aggregate, international sales decreased by 29% to $2,458,000 in the second quarter of 2005, compared to $3,446,000 in the second quarter of 2004.  For the first six months of 2005, international sales declined by 14%, compared to the same period in 2004.

          Sales in Canada increased by 20% in the second quarter.  Sales in the United Kingdom increased by 62% in the second quarter of 2005, as the efforts of the new general manager and national sales manager in the UK are beginning to show positive results. Sales in Australia/New Zealand decreased by 11% in the second quarter of 2005, compared to the same period in 2004.  The sales manager for that region was terminated during the second quarter of 2005 and a search is ongoing to find a replacement.  Sales in Malaysia/Singapore decreased by approximately 50% in the second quarter of 2005.

          Sales in Mexico decreased over 50% in the second quarter of 2005, compared to the same period in 2004.   Sales declined subsequent to price a increase and change in distributor qualification requirements, effective March 1, 2005, to put the Mexican business model in line with the rest of the markets operated by the Company.  Similar changes were made in the Philippines and sales in that market declined by 29% in the second quarter of 2005, compared to the same period in 2004.

          The following table summarizes selected items from the consolidated statement of operations, expressed as a percentage of net sales, for the periods indicated, and should be read in conjunction with the discussion of the components of the consolidated statements of operations that follow:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected data from the Consolidated

 

 

Three Months Ended

 

 

Six Months Ended

 

Statements of Operations

 

 

June 30

 

 

June 30

 

 

 

 

2005

 

 

2004

 

 

2005

 

 

2004

 

 

 

 


 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products sold

 

 

16.5

%

 

16.7

%

 

16.8

%

 

16.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Distributor royalties and commissions

 

 

39.9

%

 

40.0

%

 

40.1

%

 

39.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative

 

 

32.2

%

 

34.8

%

 

31.6

%

 

33.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

4.5

%

 

3.4

%

 

4.5

%

 

4.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

6.9

%

 

5.0

%

 

7.0

%

 

6.0

%

5



          Cost of products sold as a percentage of net sales was 16.5% in the second quarter of 2005, as compared to 16.8% in the second quarter of 2004. Cost of products sold as a percentage of net sales continues to gradually improve as the operating efficiency of the new production equipment installed in the third and fourth quarter of 2004 continues to improve and production volumes have increased. The cost of products sold as a percentage of net sales for the fourth quarter of 2004 was 18.3% and was 17.1% for the first quarter of 2005. The increase in cost of products sold for those quarters was due to start-up inefficiencies related to the installation of new production equipment.

          Distributor royalties and commissions as a percentage of net sales were 39.9% and 40.0% in the second quarter of 2005 and 2004, respectively. These expenses are governed by the distributor agreements and are directly related to the level of sales. During the first quarter of 2005, changes were made to the distributor compensation plan in the Philippines and Mexico, resulting in commission payments being made on the full retail value of the products sold. With these changes, commission payments are now being made on the full retail value of the products sold worldwide.

          Selling, general and administrative (SGA) expenses increased $876,000 in the second quarter of 2005, as compared to the second quarter of 2004. However, SGA expenses as a percentage of net sales decreased to 32.2% in the second quarter of 2005 compared to 34.8% in the second quarter of 2004. Sales expenses represented approximately $232,000 of the increase, including increased credit card fees due to the higher sales volume, and increased promotional bonuses related to sales volume. General and administrative expenses increased by approximately $718,000, primarily in salaries and bonuses, fringe benefit expenses, professional service fees, and director’s fees. Accounting fees and related expenses decreased by $148,000 in the second quarter of 2005, compared to the second quarter of 2004, in part because the Company has established an internal audit department to supplement the effort related to management’s documentation and assessment of the Company’s internal control environment. In the prior year, the Company incurred additional third party expenses with the adoption of the internal control documentation requirements of the Sarbanes-Oxley Act.

          For the first six months of 2005, SGA expenses increased by $2,318,000 compared to the first six months of 2004. However, SGA expenses as a percentage of net sales declined from 33.4% in the first six months of 2004 to 31.6% in the same period of 2005. The same items creating the significant changes during the second quarter of 2005, as compared to the same period in 2004, were responsible for the increase from the first six months of 2004 to the same period of 2005.

          During the second quarter of 2005, the Company incurred SGA expenses of approximately $143,000 in preparing for its most recent market entry, Germany. Reliv Germany GmbH began sales on July 18, 2005.

          The Company recorded income tax expense of $1,295,000 for the second quarter of 2005, an effective rate of 39.6%. In the second quarter of 2004, the Company recorded income tax expense of $802,000, an effective rate of 40.0%.

6



          Financial Condition, Liquidity and Capital Resources

          The Company generated $10,125,000 of net cash during the first six months of 2005 from operating activities, $1,203,000 was used in investing activities, and the Company used $13,134,000 in financing activities. This compares to $3,627,000 of net cash provided by operating activities, $1,348,000 used in investing activities, and $2,733,000 used in financing activities in the first six months of 2004. Cash and cash equivalents decreased by $4,315,000 to $5,837,000 as of June 30, 2005, compared to December 31, 2004.

           Significant changes in working capital items consisted of an increase in prepaid expenses and other current assets of $687,000, an increase in accounts payable and accrued expenses of $3,055,000, and a decrease in refundable income taxes payable of $1,262,000 in the first six months of 2005. The increase in prepaid expenses and other current assets is due to prepayments for future promotional trips and for policy payments for various types of business insurance to be expensed over the lives of the policies. The increase in accounts payable and accrued expenses is due to increased production volume and other expenses related to the increase in sales volume, coupled with the increase in distributor commissions payable at June 30, 2005, compared to December 31, 2004. This increase in distributor commissions payable is the result of higher worldwide sales in June 2005, compared to December 2004. The decrease in the refundable income taxes is the result of a refund received from the Internal Revenue Service on the overpayment of income tax deposits.

          The Company’s net investing activities in the first six months of 2005 consisted of $1,203,000 for capital expenditures. The most significant financing activity in the first six months of 2005 was $8,952,000 in purchases of treasury stock. The majority of this treasury stock was purchased from related parties and is described in Note 7 of the Consolidated Financial Statements. In March 2005, the Company announced that its Board of Directors had approved a stock repurchase plan of its common stock of up to $15 million over the next three years. Approximately $2,538,000 of stock was purchased from the open market during the first six months of 2005. In June 2005, the Company also paid the remaining balance of the long-term debt on its headquarters facility totaling approximately $3.5 million.

          Stockholders’ equity decreased to $10,908,000 at June 30, 2005, compared with $18,191,000 at December 31, 2004. The decrease is primarily due to a stock repurchase agreement of $4.05 million of the Company’s common stock from a former officer/director of the Company in the first quarter of 2005, stock purchases from three officer/directors of the Company totaling $5.08 million that took place in May 2005, and other treasury stock purchases that took place during the second quarter of 2005, offset by the net income of the Company during the first six months of 2005. Under the stock repurchase agreement with the former officer/director of the Company, the Company paid cash of $900,000 in March 2005 and entered into a promissory note for $3,150,000. The stock repurchase agreement is described in Note 7 of the Consolidated Financial

7



Statements. Stockholders’ equity also increased by $1,185,000 as the result of the tax benefit from the exercise of nonqualified options and warrants during the first six months of 2005.

          The Company’s working capital balance was $1,985,000 at June 30, 2005, compared to $11,467,000 at December 31, 2004. The current ratio at June 30, 2005 was 1.15, compared to 2.41 at previous year-end. In June 2005, the Company entered into a new $15 million revolving line of credit facility with the Company’s primary lender. This new facility replaced the Company’s previous operating line of credit that had a maximum borrowing limit of $1 million. The new facility expires in April 2007, and any advances accrue interest at a variable interest rate based on LIBOR. The new facility includes covenants to maintain total stockholders’ equity of not less than $10.5 million, and that the ratio of borrowings under the facility shall not exceed EBITDA by a ratio of 3.5:1. At June 30, 2005, the Company had not utilized any of the new revolving line of credit facility and was in compliance with the minimum stockholders’ equity covenant.

          Management believes that the Company’s internally generated funds, and the borrowing capacity under the new revolving line of credit facility will be sufficient to meet working capital requirements for the remainder of 2005.

          Critical Accounting Policies

          A summary of our critical accounting policies and estimates is presented on page 35 of our 2004 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 16, 2005.

          Safe Harbor Provision of the Private Securities Litigation Act of 1995 and Forward Looking           Statements.

          The statements contained in Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operation) that are not historical facts may be forward-looking statements (as such term is defined in the rules promulgated pursuant to the Securities Exchange Act of 1934) that are subject to a variety of risks and uncertainties. The forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by, and information currently available to the Company’s management. Accordingly, these statements are subject to significant risks, uncertainties and contingencies which could cause the Company’s actual growth, results, performance and business prospects and opportunities in 2005 and beyond to differ materially from those expressed in, or implied by, any such forward-looking statements. Wherever possible, words such as “anticipate,” “plan,” “expect,” “believe,” “estimate,” and similar expressions have been used to identify these forward-looking statements, but are not the exclusive means of identifying such statements. These risks, uncertainties and contingencies include, but are not limited to, the Company’s ability to continue to attract, maintain and motivate its distributors, changes in the regulatory environment affecting network marketing sales and sales of food and dietary supplements and other risks and uncertainties detailed in the Company’s other SEC filings.

8



 

 

Item 3.

Quantitative and Qualitative Disclosures of Market Risk

          The Company is exposed to various market risks, primarily foreign currency risks and interest rate risks.

          Foreign Currency Risk

          The Company’s earnings and cash flows are subject to fluctuations due to changes in foreign currency rates as it has several foreign subsidiaries and continues to explore expansion into other foreign countries. As a result, exchange rate fluctuations may have an effect on sales and gross margins. Accounting practices require that the Company’s results from operations be converted to U.S. dollars for reporting purposes. Consequently, the reported earnings of the Company in future periods may be significantly affected by fluctuations in currency exchange rates, generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar. Products manufactured by the Company for sale to the Company’s foreign subsidiaries are transacted in U.S. dollars.

          The Company enters into foreign exchange forward contracts with a financial institution to sell Canadian dollars in order to protect against currency exchange risk associated with expected future cash flows. The Company has accounted for these contracts as free standing derivatives, such that gains or losses on the fair market value of these forward exchange contracts are recorded as other income and expense in the consolidated statements of operations. The net changes in the fair value of these forward contracts as of June 30, 2005 was a cumulative expense of $57,000. As of June 30, 2005, the Company had no hedging instruments in place to offset exposure to the Australian or New Zealand dollars, Mexican or Philippine pesos, the Malaysian ringgit, the Singapore dollar, or the British pound.

          There have been no other material changes in market risk exposures during the first six months of 2005 that affect the disclosures presented in Item 7A – “Qualitative and Quantitative Disclosures Regarding Market Risk” on pages 37 and 38 of our 2004 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 16, 2005.

 

 

Item 4.

Controls and Procedures

          Our management, under the supervision and with the participation of our chief executive officer and principal financial officer, has reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures as of June 30, 2005. Based on such review and evaluation, our chief executive officer and principal financial officer have concluded that the disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2005, to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported

9



within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to the Company’s management, including the officers, as appropriate to allow timely decisions regarding required disclosure. There were no material changes in the Company’s internal control over financial reporting during the second quarter of 2005 that have materially affected or are reasonably likely to materially affect the Company’s internal controls over financial reporting.

 

 

Part II.

OTHER INFORMATION

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

ISSUER PURCHASES OF EQUITY SHARES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Total Number
of Shares
Purchased

 

Average Price
Paid per Share

 

Total Number of Shares
Purchased as Part of
Publicly Announced
Programs

 

Approximate Dollar
Value of Shares that
May Yet Be Purchased
Under the Plans or
Programs(1)

 


 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

April 1-30, 2005

 

 

118,511

 

 

$

9.69

 

 

 

118,511

 

 

$

13,774,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

May 1-31, 2005

 

 

593,253

(2)

 

$

9.57

 

 

 

58,245

 

 

$

13,177,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 1-30, 2005

 

 

67,451

 

 

$

10.66

 

 

 

67,451

 

 

$

12,458,000

 

 

 

 



 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

779,215

 

 

 

 

 

 

 

244,207

 

 

 

 

 

 

 

 



 

 

 

 

 

 



 

 

 

 

 

 

(1) In March 2005, the Company’s Board of Directors approved a share repurchase plan of up to $15 million over the next 36 months.

(2) In May 2005, the Company purchased 535,008 shares of its common stock from certain of the Company’s officers/directors at a purchase price of $9.50 per share. These purchases are described in Note 7 of the Consolidated Financial Statements.

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

At the Annual Meeting of Shareholders on May 19, 2005, the following actions were submitted and approved by a vote of the shareholders:

 

 

 

 

1.

Election of seven directors; and

 

 

 

 

2.

Ratification of the Board’s selection of Ernst & Young LLP as the Company’s independent certified public accountants.

A total of 16,716,722 shares (approximately 91% of the issued and outstanding shares of the Company) were represented by proxy or in person at the meeting. These shares were voted on the matters presented at the meeting as follows:

10



 

 

1.

For the election of directors:


 

 

 

 

 

 

 

 

 

 

Name

 

 

Total Votes For

 

 

Total Votes Against

 

 


 

 


 

 


 

 

 

 

 

 

 

 

 

 

Robert L. Montgomery

15,213,917

26,151

 

 

 

Carl W. Hastings

15,221,329

18,739

 

 

 

Donald L. McCain

15,187,537

52,531

 

 

 

Stephen M. Merrick

15,194,791

45,277

 

 

 

John B. Akin

15,161,080

76,592

 

 

 

Denis St. John

15,189,587

48,085

 

 

 

Robert M. Henry

15,185,741

51,932


 

 

2.

Ratification of the Board of Directors selection of Ernst & Young LLP as the Company’s certified public accountants.


 

 

 

 

 

 

 

 

 

 

Total Votes For

 

 

Total Votes Against

 

 

Total Broker Non-Votes
and Total Votes Abstain

 

 


 

 


 

 


 

15,180,544

14,473

45,051


 

 

Item 6.

Exhibits


 

 

 

 

 

Exhibit No.

 

 

Description

 


 

 


 

 

 

 

 

 

 3.1

 

Certificate of Incorporation (incorporated by reference to Appendix B of Form 14A of the Registrant filed on April 22, 1999).

 

 3.2

 

By-Laws (incorporated by reference to Appendix C of Form 14A of the Registrant filed on April 22, 1999).

 

 3.3

 

Amendment to By-Laws dated March 22, 2001 (incorporated by reference to Exhibit 3.3 of Form 10-K of the Registrant for the year ended December 31, 2001).

 

10.1

 

Letter Agreement dated June 7, 2005, between the Registrant and Southwest Bank of St. Louis.

 

10.2

 

Promissory Note dated June 7, 2005, between the Registrant and Southwest Bank of St. Louis.

 

31.1

 

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.

11



 

 

 

 

 

Exhibit No.

 

 

Description

 


 

 


 

 

 

 

 

 

  31.2

 

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.

 

32

 

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

12



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

Dated:  August 9, 2005

RELIV’ INTERNATIONAL, INC.

 

 

 

 

By: 

/s/ Robert L. Montgomery

 

 


 

 

 

Robert L. Montgomery, President,

 

 

Chief Executive Officer

 

 

 

 

By:

/s/ Steven D. Albright

 

 


 

 

 

Steven D. Albright, Chief

 

 

Financial Officer

13



Reliv International, Inc. and Subsidiaries

Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

 

June 30
2005

 

December 31
2004

 

 

 


 


 

 

 

(unaudited)

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

5,836,812

 

$

10,151,503

 

Accounts and notes receivable, less allowances of $23,700 in 2005 and $11,500 in 2004

 

 

568,017

 

 

872,592

 

Accounts due from employees and distributors

 

 

81,850

 

 

70,620

 

Inventories

 

 

 

 

 

 

 

Finished goods

 

 

4,399,137

 

 

3,528,135

 

Raw materials

 

 

1,635,865

 

 

1,877,210

 

Sales aids and promotional materials

 

 

526,066

 

 

491,437

 

 

 



 



 

Total inventories

 

 

6,561,068

 

 

5,896,782

 

 

 

 

 

 

 

 

 

Refundable income taxes

 

 

 

 

1,288,260

 

Prepaid expenses and other current assets

 

 

1,738,316

 

 

1,052,428

 

Deferred income taxes

 

 

320,430

 

 

286,430

 

 

 



 



 

Total current assets

 

 

15,106,493

 

 

19,618,615

 

 

 

 

 

 

 

 

 

Other assets

 

 

1,380,648

 

 

1,196,780

 

Accounts due from employees and distributors

 

 

485,772

 

 

213,123

 

 

 

 

 

 

 

 

 

Property, plant and equipment:

 

 

 

 

 

 

 

Land

 

 

829,222

 

 

829,222

 

Building

 

 

9,579,887

 

 

9,027,577

 

Machinery & equipment

 

 

4,943,662

 

 

4,926,048

 

Office equipment

 

 

1,395,298

 

 

1,092,285

 

Computer equipment & software

 

 

2,432,969

 

 

2,719,065

 

 

 



 



 

 

 

 

19,181,038

 

 

18,594,197

 

Less: Accumulated depreciation

 

 

8,678,108

 

 

8,626,048

 

 

 



 



 

Net property, plant and equipment

 

 

10,502,930

 

 

9,968,149

 

 

 



 



 

 

 

 

 

 

 

 

 

Total assets

 

$

27,475,843

 

$

30,996,667

 

 

 



 



 

See notes to financial statements.



Reliv International, Inc. and Subsidiaries

Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

 

June 30
2005

 

December 31
2004

 

 

 


 


 

 

 

(unaudited)

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable and accrued expenses:

 

 

 

 

 

 

 

Trade accounts payable and other accrued expenses

 

$

5,386,029

 

$

3,155,071

 

Distributors commissions payable

 

 

4,085,660

 

 

3,561,110

 

Sales taxes payable

 

 

474,721

 

 

493,571

 

Interest expense payable

 

 

14,823

 

 

18,000

 

Payroll and payroll taxes payable

 

 

926,638

 

 

598,321

 

 

 



 



 

Total accounts payable and accrued expenses

 

 

10,887,871

 

 

7,826,073

 

 

 

 

 

 

 

 

 

Income taxes payable

 

 

1,311,216

 

 

 

  Current maturities of long-term debt

 

 

922,308

 

 

325,895

 

 

 



 



 

Total current liabilities

 

 

13,121,395

 

 

8,151,968

 

 

 

 

 

 

 

 

 

Noncurrent liabilities:

 

 

 

 

 

 

 

Long-term debt, less current maturities

 

 

19,068

 

 

3,357,691

 

Promissory note (see Note 7)

 

 

2,200,000

 

 

 

Deferred income taxes

 

 

232,000

 

 

289,000

 

Other non-current liabilities

 

 

995,298

 

 

1,007,255

 

 

 



 



 

Total noncurrent liabilities

 

 

3,446,366

 

 

4,653,946

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

Preferred stock, par value $.001 per share; 3,000,000 shares authorized; -0- shares issued and outstanding as of 6/30/2005 and as of 12/31/2004

 

 

 

 

 

Common stock, par value $.001 per share; 30,000,000 authorized; 15,641,759 shares issued and 15,521,581 shares outstanding as of 6/30/2005; 16,323,668 shares issued and 16,320,931 shares outstanding as of 12/31/2004

 

 

15,642

 

 

16,324

 

Additional paid-in capital

 

 

22,823,676

 

 

22,661,179

 

Accumulated deficit

 

 

(9,985,348

)

 

(3,719,711

)

Accumulated other comprehensive loss:

 

 

 

 

 

 

 

  Foreign currency translation adjustment

 

 

(707,542

)

 

(758,331

)

Treasury stock

 

 

(1,238,346

)

 

(8,708

)

 

 



 



 

 

 

 

 

 

 

 

 

Total stockholders’ equity

 

 

10,908,082

 

 

18,190,753

 

 

 



 



 

 

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

27,475,843

 

$

30,996,667

 

 

 



 



 

See notes to financial statements.



Reliv International, Inc. and Subsidiaries

Consolidated Statements of Income
(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30

 

Six months ended June 30

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 


 


 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales at suggested retail

 

$

41,055,868

 

$

34,280,799

 

$

83,011,088

 

$

68,139,940

 

Less: distributor allowances on product purchases

 

 

12,509,782

 

 

10,389,594

 

 

25,485,906

 

 

20,770,903

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 

28,546,086

 

 

23,891,205

 

 

57,525,182

 

 

47,369,037

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products sold

 

 

4,711,472

 

 

4,000,626

 

 

9,654,776

 

 

7,854,905

 

Distributor royalties and commissions

 

 

11,379,011

 

 

9,562,686

 

 

23,090,727

 

 

18,883,076

 

Selling, general and administrative

 

 

9,190,021

 

 

8,314,261

 

 

18,153,307

 

 

15,835,211

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total costs and expenses

 

 

25,280,504

 

 

21,877,573

 

 

50,898,810

 

 

42,573,192

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

 

3,265,582

 

 

2,013,632

 

 

6,626,372

 

 

4,795,845

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

79,513

 

 

27,883

 

 

149,536

 

 

48,353

 

Interest expense

 

 

(117,177

)

 

(46,671

)

 

(202,667

)

 

(111,902

)

Other income

 

 

45,856

 

 

8,023

 

 

48,922

 

 

22,218

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

 

3,273,774

 

 

2,002,867

 

 

6,622,163

 

 

4,754,514

 

Provision for income taxes

 

 

1,295,000

 

 

802,000

 

 

2,580,000

 

 

1,912,000

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

1,978,774

 

 

1,200,867

 

 

4,042,163

 

 

2,842,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred dividends accrued and paid

 

 

 

 

 

 

 

 

12,292

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income available to common shareholders

 

$

1,978,774

 

$

1,200,867

 

$

4,042,163

 

$

2,830,222

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share - Basic

 

$

0.12

 

$

0.08

 

$

0.25

 

$

0.19

 

 

 



 



 



 



 

Weighted average shares

 

 

16,096,000

 

 

15,393,000

 

 

16,216,000

 

 

15,285,000

 

 

 



 



 



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share - Diluted

 

$

0.12

 

$

0.07

 

$

0.24

 

$

0.17

 

 

 



 



 



 



 

Weighted average shares

 

 

16,622,000

 

 

17,389,000

 

 

16,825,000

 

 

16,976,000

 

 

 



 



 



 



 

See notes to financial statements.



Reliv International, Inc. and Subsidiaries

Consolidated Statements of Cash Flows
(unaudited)

 

 

 

 

 

 

 

 

 

 

Six months ended June 30

 

 

 

2005

 

2004

 

 

 


 


 

 

 

 

 

 

 

 

 

Operating activities:

 

 

 

 

 

 

 

Net income

 

$

4,042,163

 

$

2,842,514

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

  Depreciation

 

 

662,159

 

 

508,767

 

  Stock-based third party compensation

 

 

33,374

 

 

38,667

 

  Tax benefit from exercise of options

 

 

1,185,000

 

 

 

  Deferred income taxes

 

 

(91,000

)

 

 

  Foreign currency transaction (gain)/loss

 

 

148,115

 

 

(21,046

)

  (Increase) decrease in accounts and notes receivable

 

 

33,748

 

 

(96,522

)

  (Increase) decrease in inventories

 

 

(672,345

)

 

(1,410,092

)

  (Increase) decrease in refundable income taxes

 

 

1,261,764

 

 

(122,158

)

  (Increase) decrease in prepaid expenses and other current assets

 

 

(686,844

)

 

(222,207

)

  (Increase) decrease in other assets

 

 

(183,847

)

 

(218,817

)

  Increase (decrease) in accounts payable and accrued expenses

 

 

3,055,235

 

 

2,476,295

 

  Increase (decrease) in income taxes payable

 

 

1,337,393

 

 

(147,560

)

 

 



 



 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

 

10,124,915

 

 

3,627,841

 

 

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(1,203,294

)

 

(1,348,385

)

 

 



 



 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

 

(1,203,294

)

 

(1,348,385

)

 

 

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

 

 

Principal payments on long-term borrowings and capital lease obligations

 

 

(3,641,559

)

 

(172,488

)

Proceeds from sale of common stock

 

 

 

 

48,601

 

Redemption of preferred stock

 

 

 

 

(975,000

)

Preferred stock dividends paid

 

 

 

 

(12,292

)

Common stock dividends paid

 

 

(565,158

)

 

(460,319

)

Repayment of loans by officers and directors

 

 

 

 

 

Proceeds from options exercised

 

 

24,183

 

 

132,388

 

Purchase of stock for treasury

 

 

(8,951,805

)

 

(1,293,980

)

 

 



 



 

 

 

 

 

 

 

 

 

Net cash used in financing activities

 

 

(13,134,339

)

 

(2,733,090

)

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(101,973

)

 

(39,218

)

 

 



 



 

 

 

 

 

 

 

 

 

Decrease in cash and cash equivalents

 

 

(4,314,691

)

 

(492,852

)

 

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

 

10,151,503

 

 

7,902,508

 

 

 



 



 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

5,836,812

 

$

7,409,656

 

 

 



 



 

See notes to financial statements



Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)

June 30, 2005

 

 

Note 1—

Basis of Presentation

 

 

 

The accompanying unaudited consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments which management believes necessary (which primarily include normal recurring accruals) to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2004, filed March 16, 2005 with the Securities and Exchange Commission.

 

 

Note 2—

Reclassifications

 

 

 

Certain prior year amounts have been reclassified to conform to the current year presentation.

 

 

Note 3—

Earnings per Share

 

 

 

The following table sets forth the computation of basic and diluted earnings per share:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30

 

Six months ended June 30

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 


 


 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator for basic and diluted earnings per share—net income available to common shareholders

 

$

1,978,774

 

$

1,200,867

 

$

4,042,163

 

$

2,830,222

 

Effect of convertible preferred stock:

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends on preferred stock

 

 

 

 

 

 

 

 

12,292

 

 

 






 






 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator for diluted earnings per share

 

$

1,978,774

 

$

1,200,867

 

$

4,042,163

 

$

2,842,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator for basic earnings per share—weighted average shares

 

 

16,096,000

 

 

15,393,000

 

 

16,216,000

 

 

15,285,000

 

Effect of convertible preferred stock and   dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible preferred stock

 

 

 

 

 

 

 

 

106,000

 

Employee stock options and other warrants

 

 

526,000

 

 

1,996,000

 

 

609,000

 

 

1,585,000

 

 

 






 






 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator for diluted earnings per share—adjusted weighted average shares

 

 

16,622,000

 

 

17,389,000

 

 

16,825,000

 

 

16,976,000

 

 

 






 






 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

0.12

 

$

0.08

 

$

0.25

 

$

0.19

 

 

 






 






 

Diluted earnings per share

 

$

0.12

 

$

0.07

 

$

0.24

 

$

0.17

 

 

 






 






 




Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)

June 30, 2005

 

 

Note 4—

New Pronouncements

 

 

 

The Securities and Exchange Commission has deferred the adoption date of Statement of Financial Accounting Standard (“SFAS”) No. 123R, “Share-Based Payment,” to the beginning of the fiscal year that begins after June 15, 2005, (January 1, 2006 for calendar year companies) from a July 1, 2005 adoption date previously set by the FASB. SFAS No. 123R requires the recognition of share-based payments, including employee stock options, in the income statement based on their fair values. The Company expects to adopt this standard on January 1, 2006. Based on stock option grants made in prior years, the Company estimates it will (assuming the modified prospective method is used) recognize expense for stock options for the year ending December 31, 2006 of $63,000, net of taxes.

 

 

Note 5—

Comprehensive Income

 

 

 

Total comprehensive income was $2,013,889 and $4,092,951 for the three and six months ended June 30, 2005, respectively. For the three and six months ended June 30, 2004, comprehensive income was $1,082,067 and $2,750,443, respectively. The Company’s only component of other comprehensive income is the foreign currency translation adjustment.

 

 

Note 6—

Stock-Based Compensation

 

 

 

The Company accounts for its stock-based compensation plans under the recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations. No stock-based employee compensation cost is reflected in net income, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant.  The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation, to stock-based employee compensation.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30

 

Six months ended June 30

 

 

 

2005

 

2004

 

2005

 

2004

 

 

 


 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income available to common shareholders, as reported

 

$

1,978,774

 

$

1,200,867

 

$

4,042,163

 

$

2,830,222

 

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

 

 

636,095

 

 

369

 

 

1,490,595

 

 

46,328

 

 

 






 






 

Pro forma net income available to common shareholders

 

$

1,342,679

 

$

1,200,498

 

$

2,551,568

 

$

2,783,894

 

 

 






 






 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic—as reported

 

$

0.12

 

$

0.08

 

$

0.25

 

$

0.19

 

 

 






 






 

Basic—pro forma

 

$

0.08

 

$

0.08

 

$

0.16

 

$

0.18

 

 

 






 






 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted—as reported

 

$

0.12

 

$

0.07

 

$

0.24

 

$

0.17

 

 

 






 






 

Diluted—pro forma

 

$

0.08

 

$

0.07

 

$

0.15

 

$

0.16

 

 

 






 






 


 

 

 

The Company issued 523,109 shares for the six months ended June 30, 2005, for stock option and warrant exercises. For the six months ended June 30, 2004, 785,494 shares were issued for such exercises. 




Reliv’ International, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(Unaudited)

June 30, 2005

 

 

Note 7—

Related Party Tranactions

 

 

 

On March 14, 2005, the Company entered into an employment agreement and a stock redemption agreement with an officer/director. The employment agreement has a term of three years and includes a non-compete clause which extends for six years. Under the stock redemption agreement, the Company will purchase 450,000 shares of the common stock of the Company at a price of $9.00 per share. Payment of the purchase price for the shares will be made in installments over a period not to exceed four years at an interest rate of 4%. The first principal payment of $900,000 was made on March 31, 2005, and future principal payments of $900,000 are due on March 31, 2006, and 2007, and principal payments of $675,000 are due on March 31, 2008 and 2009.

 

 

 

On March 22, 2005, the Company purchased 39,193 shares of the Company’s common stock from a former officer of the Company at a price of $9.00 per share.

 

 

 

In May 2005, the Company purchased an aggregate of 535,008 shares of the Company’s common stock from three officer/directors at a price of $9.50 per share.

 

 

 

The retirement of the shares purchased in these various transactions reduced stockholders’ equity by $9,485,000 as of June 30, 2005.